Paul M. Yen

8 College Road
Singapore, 169587, Singapore

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 108 publications

High salt supplementation of a MASH-inducing diet causes lean MASH phenotype with increased hepatic urea cycle activity and EIF5A hypusination.

High salt supplementation of a MASH-inducing diet causes lean MASH phenotype with increased hepatic urea cycle activity and EIF5A hypusination.

Journal: Molecular metabolism

Published: March 02, 2026

Levothyroxine for Metabolic Dysfunction-Associated Steatohepatitis: It Is the Prime Time for Randomized Controlled Trials.

Levothyroxine for Metabolic Dysfunction-Associated Steatohepatitis: It Is the Prime Time for Randomized Controlled Trials.

Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists

Published: February 16, 2026

Correction to: Repurposing Levothyroxine for managing metabolic dysfunction-associated steatotic liver disease.

Correction to: Repurposing Levothyroxine for managing metabolic dysfunction-associated steatotic liver disease.

Journal: Endocrine

Published: October 29, 2025

Aging and Western Diet Synergistically Impair Hepatic Thyroid Hormone Signaling to Promote Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Mice.

Aging and Western Diet Synergistically Impair Hepatic Thyroid Hormone Signaling to Promote Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Mice.

Journal: Aging cell

Published: September 10, 2025

Elevated Homocysteine is Associated With Liver Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease in a Sex- and Menopause-Specific Manner.

Elevated Homocysteine is Associated With Liver Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease in a Sex- and Menopause-Specific Manner.

Journal: Gastro hep advances

Published: August 19, 2025

Repurposing levothyroxine for managing metabolic dysfunction-associated steatotic liver disease.

Repurposing levothyroxine for managing metabolic dysfunction-associated steatotic liver disease.

Journal: Endocrine

Published: July 29, 2025

Metabolic and Functional Cross Talk Between the Thyroid and Liver.

Metabolic and Functional Cross Talk Between the Thyroid and Liver.

Journal: Thyroid : official journal of the American Thyroid Association

Published: May 27, 2025

Metabolic impact of dietary glycine supplementation in individuals with severe obesity.

Metabolic impact of dietary glycine supplementation in individuals with severe obesity.

Journal: Scientific reports

Published: March 29, 2025

ESRRA (estrogen related receptor, alpha) induces ribosomal protein RPLP1-mediated adaptive hepatic translation during prolonged starvation.

ESRRA (estrogen related receptor, alpha) induces ribosomal protein RPLP1-mediated adaptive hepatic translation during prolonged starvation.

Journal: Autophagy

Published: February 12, 2025

Actions of thyroid hormones and thyromimetics on the liver.

Actions of thyroid hormones and thyromimetics on the liver.

Journal: Nature reviews. Gastroenterology & hepatology

Published: September 09, 2024

Esrra regulates Rplp1-mediated translation of lysosome proteins suppressed in metabolic dysfunction-associated steatohepatitis and reversed by alternate day fasting.

Esrra regulates Rplp1-mediated translation of lysosome proteins suppressed in metabolic dysfunction-associated steatohepatitis and reversed by alternate day fasting.

Journal: Molecular metabolism

Published: May 15, 2024

Autophagy and hepatic lipid metabolism: mechanistic insight and therapeutic potential for MASLD.

Autophagy and hepatic lipid metabolism: mechanistic insight and therapeutic potential for MASLD.

Journal: npj metabolic health and disease

Published: March 30, 2024

Showing 1-12 of 108

Last Updated: 09/26/2026